Page last updated: 2024-09-03

l 368899 and dronabinol

l 368899 has been researched along with dronabinol in 1 studies

Compound Research Comparison

Studies
(l 368899)
Trials
(l 368899)
Recent Studies (post-2010)
(l 368899)
Studies
(dronabinol)
Trials
(dronabinol)
Recent Studies (post-2010) (dronabinol)
460308,3077853,094

Protein Interaction Comparison

ProteinTaxonomyl 368899 (IC50)dronabinol (IC50)
Cannabinoid receptor 1Rattus norvegicus (Norway rat)0.218
Cannabinoid receptor 1Homo sapiens (human)0.0028
Cannabinoid receptor 2 Homo sapiens (human)0.0095
Cannabinoid receptor 2Rattus norvegicus (Norway rat)0.218

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowen, RC; Cui, SS; Gu, GB; Hannesson, DK; Yu, PH; Zhang, X1

Other Studies

1 other study(ies) available for l 368899 and dronabinol

ArticleYear
Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001, Dec-15, Volume: 21, Issue:24

    Topics: Animals; Behavior, Animal; Brain; Camphanes; Cannabinoids; Densitometry; Dose-Response Relationship, Drug; Dronabinol; Immunohistochemistry; In Situ Hybridization; Lithium; Male; Morpholines; Neurons; Oxytocin; Piperazines; Proto-Oncogene Proteins c-fos; Pyrazoles; Radioimmunoassay; Rats; Rats, Long-Evans; Receptors, Cannabinoid; Receptors, Drug; Receptors, Oxytocin; Substance Withdrawal Syndrome

2001